Isracann Biosciences Inc. — Form D
Isracann Biosciences Inc. of VANCOUVER, A1, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-30. The offering totals $1.2M, of which $393K was reported sold. Industry: Other Technology.
Offering
- Filed: 2019-05-30
- Form: D
- Accession: 0001183740-19-000117
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.2M
- Amount sold: $393K
- Remaining: $786K
- Investors: 26
- Date of first sale: 2019-05-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-340670
Issuer
- Name: Isracann Biosciences Inc.
- CIK: 0001726529
- Entity type: Corporation
- Jurisdiction: BRITISH COLUMBIA, CANADA
- Address: 1600 - 595 BURRARD STREET, VANCOUVER, A1, V7X 1L3
- Phone: 6047889533
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Frederick Stearman | Director | Vancouver, A1 |
| John Veltheer | Director | Vancouver, A1 |
| Charlie Kiser | Executive Officer | Vancouver, A1 |
| Frederick Stearman | Executive Officer | Vancouver, A1 |
| Matthew Chatterton | Executive Officer | VANCOUVER, A1 |
| Sean Bromley | Director | Vancouver, A1 |
| Yana Popova | Director | Reno, NV |
| Yana Popova | Executive Officer | Reno, NV |
| Desmond Balakrishnan | Director | VANCOUVER, A1 |
| James Thompson | Executive Officer | Rushford, MN |
| George Vrabec | Director | Vancouver, A1 |
| Phil Floucault | Director | Vancouver, A1 |
| Phil Floucault | Executive Officer | Vancouver, A1 |
| Arbel Irit | Director | Vancouver, A1 |
Other filings by this issuer (3)
More